Oncology Realising the promise of genomic testing across oncology Unlocking the secrets of the human genome has long been an ambitious pursuit for researchers around the world.
Oncology Oncology market dominance: As easy as ADC? Antibody-drug conjugates are coming back to the fore, with talks of multi-billion dollar buyouts and a rapidly growing number of approvals.
Oncology Diversity by design: the importance of DE&I in oncology tria... “First, do no harm”; is an ethical axiom at the heart of medical research; physicians worldwide pledge to uphold the oath to serve patients.
Oncology Phesi’s Dr Gen Li: New approaches to clinical trials in canc... Dr Gen Li, founder and president of Phesi, a provider of AI-powered clinical development analytics, products and solutions, discusses some of the latest challenges facing the industry, incl
Oncology Realising the promise of cancer vaccines For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. And for good reason.
Oncology Deep Dive: Oncology 2022 Eradicating cancer is an ambitious goal for oncologists and life science companies around the world.
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
